Cargando…

Risk of malignancies in patients with inflammatory bowel disease who used thiopurines as compared with other indications: a territory-wide study

AIMS: Thiopurines are believed to increase cancer risks, but data from Asian patients are sparse. We determined the risks of malignancies in thiopurine users with inflammatory bowel disease (IBD) or other indications from Hong Kong. METHODS: All patients who had received thiopurines between 2005 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Kelvin Y. C., Guo, Chuan-Guo, Wong, Irene O. L., Chen, Lijia, Chung, Ho Yin, Cheung, Ka Shing, Leung, Wai K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682226/ https://www.ncbi.nlm.nih.gov/pubmed/33281936 http://dx.doi.org/10.1177/1756284820967275

Ejemplares similares

Association Between Famotidine Use and COVID-19 Severity in Hong Kong: A Territory-wide Study
por: Cheung, Ka Shing, et al.
Publicado: (2021)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

Association between antibiotic consumption and colon and rectal cancer development in older individuals: A territory‐wide study
por: Cheung, Ka Shing, et al.
Publicado: (2022)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
por: Gazouli, Μaria, et al.
Publicado: (2012)

Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis
por: Liu, Yue-Ping, et al.
Publicado: (2015)

Use of thiopurines in inflammatory bowel disease: an update
por: Singh, Arshdeep, et al.
Publicado: (2022)

Antibiotic Use Prior to COVID-19 Vaccine Is Associated with Higher Risk of COVID-19 and Adverse Outcomes: A Propensity-Scored Matched Territory-Wide Cohort
por: Cheung, Ka Shing, et al.
Publicado: (2023)

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
por: Zakerska-Banaszak, Oliwia, et al.
Publicado: (2022)

Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
por: Zhou, Jiandong, et al.
Publicado: (2021)

Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease
por: Cococcioni, Lucia, et al.
Publicado: (2022)

Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease
por: Parkar, Suruchi P, et al.
Publicado: (2017)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
por: Cornish, Jack S., et al.
Publicado: (2020)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
por: Tominaga, Keiichi, et al.
Publicado: (2021)

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

Use of Thiopurines and Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Diseases: A Meta-Analysis
por: Gong, Jianfeng, et al.
Publicado: (2013)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

Monitoring Thiopurine Metabolites in Korean Pediatric Patients with Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2014)

Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective
por: Axelrad, Jordan E, et al.
Publicado: (2016)

How I treat my inflammatory bowel disease-patients with thiopurines?
por: Meijer, Berrie, et al.
Publicado: (2016)

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
por: Luber, Raphael P., et al.
Publicado: (2019)

The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong—A Territory-Wide Cohort Study
por: Wong, Jeffrey Sum-Lung, et al.
Publicado: (2021)

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
por: Simsek, Melek, et al.
Publicado: (2017)

Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018)

Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients
por: Ding, Liang, et al.
Publicado: (2021)

Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients
por: Fortes, Flora Maria Lorenzo, et al.
Publicado: (2023)

Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease
por: Mak, Lung-Yi, et al.
Publicado: (2020)

Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilization in Singapore
por: Yeo, Jia Qi, et al.
Publicado: (2022)

Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose
por: Yin, Dandan, et al.
Publicado: (2017)

Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients
por: Bastida, Guillermo, et al.
Publicado: (2010)

Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy
por: Seinen, Margien L., et al.
Publicado: (2016)

The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?
por: Chhaya, Vivek, et al.
Publicado: (2013)

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease
por: Lord, James D, et al.
Publicado: (2017)

Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population
por: Zalizko, Polina, et al.
Publicado: (2020)

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
por: Matsuoka, Katsuyoshi
Publicado: (2020)

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy
por: Jansen, Fenna M., et al.
Publicado: (2023)

Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism
por: Zimdahl Kahlin, Anna, et al.
Publicado: (2020)

Epidemiology and natural history of Wilson’s disease in the Chinese: A territory-based study in Hong Kong between 2000 and 2016
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uo5q8n8okgetvg7722o5hcf077